We are live on ! Find out more
Aspect Partners

Aspect Partners Portfolio holdings

AUM $264M Turnover 5.16%
1-Year Est. Return 15.76%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+15.76%
3 Year Est. Return
+66.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$264M
AUM Growth
-$3.69M
Cap. Flow
-$4.8M
Cap. Flow %
-1.81%
Top 10 Hldgs %
59.87%
Holding
698
New
19
Increased
176
Reduced
151
Closed
17
Avg Time Held
2 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
2 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EXC icon
501
Exelon
EXC
$46.2B
$2.5K ﹤0.01%
62
+3
+5% +$134
2023 Q4
11 quarters
AAON icon
502
Aaon
AAON
$5.74B
$2.5K ﹤0.01%
30
– –
2023 Q4
11 quarters
BKR icon
503
Baker Hughes
BKR
$53.2B
$2.47K ﹤0.01%
45
– –
2023 Q4
11 quarters
CARR icon
504
Carrier Global
CARR
$46.6B
$2.47K ﹤0.01%
45
-1
-2% -$62
2023 Q4
11 quarters
CCL icon
505
Carnival Corporation Ltd
CCL
$36.4B
$2.45K ﹤0.01%
100
– –
2024 Q1
10 quarters
RC icon
506
Ready Capital
RC
$167M
$2.33K ﹤0.01%
2,005
– –
2023 Q4
11 quarters
USB icon
507
US Bancorp
USB
$93.5B
$2.31K ﹤0.01%
40
+16
+67% +$999
2023 Q4
11 quarters
TCAI icon
508
Tortoise AI Infrastructure ETF
TCAI
$192M
$2.3K ﹤0.01%
49
+8
+20% +$381
2026 Q1
2 quarters
DDOG icon
509
Datadog
DDOG
$92.6B
$2.29K ﹤0.01%
8
– –
2024 Q4
7 quarters
SOXX icon
510
iShares Semiconductor ETF
SOXX
$39.6B
$2.28K ﹤0.01%
4
– –
2023 Q4
11 quarters
SUPN icon
511
Supernus Pharmaceuticals
SUPN
$2.45B
$2.24K ﹤0.01%
52
– –
2025 Q3
4 quarters
ARKK icon
512
ARK Innovation ETF
ARKK
$6.17B
$2.23K ﹤0.01%
25
+14
+127% +$1.14K
2026 Q2
1 quarter
MSCI icon
513
MSCI
MSCI
$45.1B
$2.16K ﹤0.01%
4
-5
-56% -$2.86K
2023 Q4
11 quarters
MMED icon
514
MiniMed Group Inc
MMED
$5.15B
$2.1K ﹤0.01%
108
+7
+7% +$135
2026 Q2
1 quarter
COR icon
515
Cencora
COR
$64.6B
$2.1K ﹤0.01%
7
– –
2023 Q4
11 quarters
IDXX icon
516
Idexx Laboratories
IDXX
$44.6B
$2.09K ﹤0.01%
4
– –
2023 Q4
11 quarters
VT icon
517
Vanguard Total World Stock ETF
VT
$80.8B
$2.05K ﹤0.01%
13
– –
2026 Q1
2 quarters
TGT icon
518
Target
TGT
$71.8B
$2.04K ﹤0.01%
13
– –
2023 Q4
11 quarters
SYY icon
519
Sysco
SYY
$41.3B
$2.03K ﹤0.01%
26
– –
2023 Q4
11 quarters
WEC icon
520
WEC Energy
WEC
$36.5B
$2.02K ﹤0.01%
20
-2
-9% -$218
2023 Q4
11 quarters
TFC icon
521
Truist Financial
TFC
$59.2B
$1.99K ﹤0.01%
43
-346
-89% -$17.6K
2023 Q4
11 quarters
TEVA icon
522
Teva Pharmaceutical Industries Limited
TEVA
$46.9B
$1.98K ﹤0.01%
50
– –
2024 Q3
8 quarters
AMP icon
523
Ameriprise Financial
AMP
$43.9B
$1.97K ﹤0.01%
4
– –
2023 Q4
11 quarters
KLAC icon
524
KLA
KLAC
$193B
$1.95K ﹤0.01%
10
– –
2025 Q3
4 quarters
VMRK icon
525
Vivmark Residential
VMRK
$49.2B
$1.88K ﹤0.01%
31
+26
+520% +$1.72K
2023 Q4
11 quarters

Similar funds

Aspect Partners's Q3 2026 Portfolio in Review

As of Q3 2026, Aspect Partners held 698 positions worth $264M, down 1.4% from $268M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Aspect Partners's Q3 2026 filing shows 19 new, 176 increased, 151 reduced and 17 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 245,690 shares worth $20M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $9.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Technology and Financials.

  • Aspect Partners's largest Q3 2026 buy was iShares 1-3 Year Treasury Bond ETF: 245,690 shares worth $20M.
  • Aspect Partners added most to Distillate Small/Mid Cash Flow ETF in Q3 2026, an estimated $846K increase.
  • Aspect Partners's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.9M.
  • Aspect Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q3 2026, selling an estimated $27.5K.
  • Aspect Partners's ten largest holdings make up 60% of its $264M portfolio in Q3 2026.
  • Aspect Partners opened 19 new positions and closed 17 in Q3 2026.
  • Aspect Partners's portfolio value fell 1.4% quarter-over-quarter to $264M.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.